These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20856163)

  • 1. Antibody responses to hepatitis A virus vaccination in thai hiv-infected children with immune recovery after antiretroviral therapy.
    Sudjaritruk T; Sirisanthana T; Sirisanthana V
    Pediatr Infect Dis J; 2011 Mar; 30(3):256-9. PubMed ID: 20856163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
    Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
    J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children.
    Saksawad R; Likitnukul S; Warachit B; Hanvivatvong O; Poovorawan Y; Puripokai P
    Vaccine; 2011 Jun; 29(29-30):4735-8. PubMed ID: 21570433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
    Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
    Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents.
    Siberry GK; Coller RJ; Henkle E; Kiefner C; Joyner M; Rogers J; Chang J; Hutton N
    Pediatr Infect Dis J; 2008 May; 27(5):465-8. PubMed ID: 18382387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
    Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
    Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
    Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to hepatitis A vaccine in HIV-positive patients.
    Weissman S; Feucht C; Moore BA
    J Viral Hepat; 2006 Feb; 13(2):81-6. PubMed ID: 16436125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Siriaksorn S; Puthanakit T; Sirisanthana T; Sirisanthana V
    Vaccine; 2006 Apr; 24(16):3095-9. PubMed ID: 16488516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy.
    Lao-araya M; Puthanakit T; Aurpibul L; Sirisanthana T; Sirisanthana V
    Vaccine; 2007 Jul; 25(29):5324-9. PubMed ID: 17566615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children.
    Gouvea AF; De Moraes-Pinto MI; Ono E; Dinelli MI; Machado DM; Weckx LY; Succi RC
    Clin Infect Dis; 2005 Aug; 41(4):544-8. PubMed ID: 16028166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to hepatitis A vaccination in HIV-infected men in Greece.
    Kourkounti S; Mavrianou N; Paparizos VA; Kyriakis K; Hatzivassiliou M; Kordosis T; Katsambas A
    Int J STD AIDS; 2012 Jul; 23(7):464-7. PubMed ID: 22843998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.
    Weinberg A; Huang S; Fenton T; Patterson-Bartlett J; Gona P; Read JS; Dankner WM; Nachman S;
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):17-24. PubMed ID: 19617848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
    Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
    Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].
    Jabłonowska E; Kuydowicz J; Małolepsza E
    Przegl Epidemiol; 2008; 62(3):605-12. PubMed ID: 19108525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.